Skip to main content
. 2022 Nov 17;9:1041668. doi: 10.3389/fmed.2022.1041668

TABLE 1.

Population characteristics.

Number of evaluated patients 73
N %
Age:
<65 years 46 63.0
≥65 years 27 37.0
Sex:
Male 52 71.2
Female 21 28.8
Patient location before admission:
Home 56 76.7
Transferred from another hospital or from a long-term facility 17 23.3
Geographical area (Italy):
North 45 61.6
Center/south 28 38.4
Period of hospitalization:
February 2020–September 2020 34 46.6
October 2020–April 2021 39 53.4
Comorbidities:
Chronic respiratory disease 16 21.9
Neoplastic disease 9 12.3
Diabetes 18 24.7
Chronic renal failure 13 17.8
Antibiotics in the first 48 h from admission:
Any 40 54.8
Azithromycin 18 24.7
Ceftriaxone 17 23.3
Piperacillin-tazobactam 11 15.1
Others 10 13.7
Systemic steroids in the first 48 h from admission 30 41.1
Number of microorganisms isolated from blood cultures during hospitalization:
One, single episode/culture 45 61.6
Two, single episode/culture 6 8.2
Two, different episodes/cultures 17 23.3
Three, different episodes/cultures 4 5.5
Four, different episodes/cultures 1 1.4
Admitted to Intensive Care Unit (ICU) during hospitalization 53 72.6
Sepsis reported as a cause of death in the death certificate 36 49.3
Days from hospital admission to ICU admission (median, IQR) 3 (0–8)
Days from hospital admission to first positive blood culture (median, IQR) 20 (13–29.5)
Days from ICU admission to first positive blood culture (median, IQR) 14 (8–20.5)
Days from hospital admission to death (median, IQR) 35 (21–59)
Days from ICU admission to death (median, IQR) 34 (16–50)

IQR, interquartile range.